Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Obesity 8Overweight 3Obesity-Related Malignant Neoplasm 3Endometrial Neoplasms 3Breast Neoplasms 3Motor Activity 2Head and Neck Neoplasms 2Weight Loss 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Sedentary Behavior 1Sarcoma 1Rectal Neoplasms 1Psychological Well-Being 1Prostatic Neoplasms 1Pharyngeal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Mucositis 1Mouth Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Inflammation 1Hodgkin Disease 1Hematopoietic and Lymphoid System Neoplasm 1

Interventions

Radiotherapy 9Cisplatin 8Fibroblast Growth Factor 7 6Low-Level Light Therapy 5angiotensin I (1-7) 4Radiation 4Injections 4Propolis 3Morphine 3Methotrexate 3Leucovorin 3Drug Therapy 3Cryotherapy 3glucarpidase 2aluminum hydroxide, magnesium hydroxide, drug combination 2Xylitol 2Water 2Radiotherapy, Intensity-Modulated 2RRx-001 2Probiotics 2Pentoxifylline 2Mouthwashes 2Melphalan 2Lidocaine 2Ketamine 2Interleukin 1 Receptor Antagonist Protein 2Honey 2Glutamine 2Gabapentin 2Fluorouracil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mucositis × Methods × Other × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡